Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Abiraterone acetate: Phase I data

In a dose-escalation, U.S. Phase I trial in 27 chemotherapy-naïve patients

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE